首页> 外文期刊>Journal of Translational Medicine >Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles
【24h】

Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles

机译:IR780染料掺入磷脂纳米颗粒对脑肿瘤的近红外荧光成像

获取原文
获取外文期刊封面目录资料

摘要

Background Near-IR fluorescence (NIRF) imaging is becoming a promising approach in preclinical tumor detection and clinical image-guided oncological surgery. While heptamethine cyanine dye IR780 has excellent tumor targeting and imaging potential, its hydrophobic property limits its clinical use. In this study, we developed nanoparticle formulations to facilitate the use of IR780 for fluorescent imaging of malignant brain tumor. Methods Self-assembled IR780-liposomes and IR780-phospholipid micelles were prepared and their NIRF properties were characterized. The intracellular accumulation of IR780-nanoparticles in glioma cells were determined using confocal microscopy. The in vivo brain tumor targeting and NIRF imaging capacity of IR780-nanoparticles were evaluated using U87MG glioma ectopic and orthotopic xenograft models and a spontaneous glioma mouse model driven by RAS/RTK activation. Results The loading of IR780 into liposomes or phospholipid micelles was efficient. The particle diameter of IR780-liposomes and IR780-phospholipid micelles were 95 and 26?nm, respectively. While stock solutions of each preparation were maintained at ready-to-use condition, the IR780-phospholipid micelles were more stable. In tissue culture cells, IR780-nanoparticles prepared by either method accumulated in mitochondria, however, in animals the IR780-phospholipid micelles showed enhanced intra-tumoral accumulation in U87MG ectopic tumors. Moreover, IR780-phospholipid micelles also showed preferred intracranial tumor accumulation and potent NIRF signal intensity in glioma orthotopic models at a real-time, non-invasive manner. Conclusion The IR780-phospholipid micelles demonstrated tumor-specific NIRF imaging capacity in glioma preclinical mouse models, providing great potential for clinical imaging and image-guided surgery of brain tumors.
机译:背景技术近红外荧光(NIRF)成像正在成为临床前肿瘤检测和临床图像引导的肿瘤外科手术中的一种有前途的方法。尽管七甲胺花菁染料IR780具有出色的肿瘤靶向和成像潜能,但其疏水性限制了其临床应用。在这项研究中,我们开发了纳米颗粒制剂,以促进IR780在恶性脑肿瘤的荧光成像中的应用。方法制备自组装的IR780-脂质体和IR780-磷脂微团,并对其NIRF性质进行表征。使用共聚焦显微镜确定IR780-纳米颗粒在神经胶质瘤细胞中的细胞内积累。使用U87MG胶质瘤异位和原位异种移植模型以及由RAS / RTK激活驱动的自发性胶质瘤小鼠模型评估IR780纳米粒子的体内脑肿瘤靶向和NIRF成像能力。结果将IR780装载到脂质体或磷脂胶束中是有效的。 IR780-脂质体和IR780-磷脂微团的粒径分别为95和26?nm。当每种制剂的储备溶液保持在即用状态时,IR780磷脂微团更稳定。在组织培养细胞中,通过任一种方法制备的IR780纳米颗粒都积累在线粒体中,但是在动物体内,IR780磷脂微团在U87MG异位肿瘤中显示出增强的肿瘤内积累。此外,IR780磷脂微团还以实时,非侵入性的方式在神经胶质瘤原位模型中显示出优选的颅内肿瘤蓄积和有效的NIRF信号强度。结论IR780磷脂胶束在神经胶质瘤临床前小鼠模型中显示了肿瘤特异性NIRF成像能力,为脑肿瘤的临床成像和图像指导手术提供了巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号